Literature DB >> 9370540

Improvement of post-gadolinium contrast with magnetization transfer.

P Huot1, V Dousset, F Hatier, P Degreze, P Carlier, J M Caillé.   

Abstract

Magnetization transfer (MT) provides post-gadolinium contrast improvement through decreasing the tissue signal. Our study had two aims: to analyse the effect of MT qualitatively and quantitatively in 13 patients, and to analyse in vitro the competition between two relaxation phenomena, dipole-dipole which is characteristic of MT and proton - electron which is characteristic of gadolinium. Contrast between lesion and white matter improved from 20.6 % before MT to 65.1 % after MT, enabling new lesions to be detected in two patients. The improvement was due mainly to the proton - electron effect of gadolinium rather than the dipole relaxation of MT. These results are in agreement with those in the literature. The existence of spontaneous high-signal induced by MT in the absence of gadolinium indicates that it is preferable to perform an MT sequence before and after administration of gadolinium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370540     DOI: 10.1007/pl00006889

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.

Authors:  M M Gavra; C Voumvourakis; A D Gouliamos; C Sfagos; L J Vlahos
Journal:  Neuroradiology       Date:  2004-02-19       Impact factor: 2.804

2.  Magnetization transfer ratio in neuro-Behçet disease.

Authors:  Yonca Anik; Zekiye Kural; Ali Demirci; Gür Akansel; Sibel Aksu; Metin Vural
Journal:  Neuroradiology       Date:  2005-01-20       Impact factor: 2.804

3.  Magnetization transfer imaging of normal and abnormal testis: preliminary results.

Authors:  Athina C Tsili; Alexandra Ntorkou; Dimitrios Baltogiannis; Anastasios Sylakos; Sotirios Stavrou; Loukas G Astrakas; Vasilios Maliakas; Nikolaos Sofikitis; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2015-06-12       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.